PRKAA1 gRNA (BRDN0001146526) Citations (1)

Originally described in: Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.
Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE Nat Biotechnol. 2016 Jan 18. doi: 10.1038/nbt.3437. PubMed Journal

---

Articles Citing PRKAA1 gRNA (BRDN0001146526)

Articles
Endothelial AMP-Activated Kinase alpha1 Phosphorylates eNOS on Thr495 and Decreases Endothelial NO Formation. Zippel N, Loot AE, Stingl H, Randriamboavonjy V, Fleming I, Fisslthaler B. Int J Mol Sci. 2018 Sep 13;19(9). pii: ijms19092753. doi: 10.3390/ijms19092753. PubMed

If you have published an article using this material, please email us at to have your article added to this page.